Tolvaptan promotes urinary excretion of sodium and urea: a retrospective cohort study.

about

Tolvaptan promotes urinary excretion of sodium and urea: a retrospective cohort study.

Item

http://www.wikidata.org/entity/Q48156467

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Tolvaptan promotes urinary excretion of sodium and urea: a retrospective cohort study.

@en

Tolvaptan promotes urinary excretion of sodium and urea: a retrospective cohort study.

@nl

type

Item

label

Tolvaptan promotes urinary excretion of sodium and urea: a retrospective cohort study.

@en

Tolvaptan promotes urinary excretion of sodium and urea: a retrospective cohort study.

@nl

prefLabel

Tolvaptan promotes urinary excretion of sodium and urea: a retrospective cohort study.

@en

Tolvaptan promotes urinary excretion of sodium and urea: a retrospective cohort study.

@nl

P1476

Tolvaptan promotes urinary excretion of sodium and urea: a retrospective cohort study.

@en

P2093

Hirotsugu Iwatani

http://www.w3.org/2001/XMLSchema#string

Takayuki Hamano

http://www.w3.org/2001/XMLSchema#string

Yoshiki Kimura

http://www.w3.org/2001/XMLSchema#string

Yoshitaka Isaka

http://www.w3.org/2001/XMLSchema#string

P2860

Focus on renal congestion in heart failure

Sodium excretion in response to vasopressin and selective vasopressin receptor antagonists

Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.

Urinary concentrating defect in mice with selective deletion of phloretin-sensitive urea transporters in the renal collecting duct

Renal urea transporters. Direct and indirect regulation by vasopressin.

Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial.

Protein carbamylation in kidney disease: pathogenesis and clinical implications

Renal phenotype of UT-A urea transporter knockout mice.

Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials.

P2888

s10157-017-1475-9

P31

scholarly article

P356

10.1007/S10157-017-1475-9

http://www.w3.org/2001/XMLSchema#string

P50

Masayuki Mizui

Satoshi Minami

P577

2017-10-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29052786

http://www.w3.org/2001/XMLSchema#string